Skip to main content

#162058

Anti-deltaNp63 [deltaNp63-1.1]

Cat. #162058

Anti-deltaNp63 [deltaNp63-1.1]

Cat. #: 162058

Sub-type: Primary antibody

Availability: 3-4 weeks

Target: tumour protein p63 lacking the transactivation domain (TA)

Class: Monoclonal

Reactivity: Human ; mouse ; rat

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Institute: Moravian Biotechnology

Tool Details
Target Details
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-deltaNp63 [deltaNp63-1.1]
  • Research fields: Cell signaling and signal transduction
  • Clone: deltaNp63-1.1
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Molecular weight: 72 kDa
  • Reactivity: Human ; mouse ; rat
  • Host: Mouse
  • Description: Antibody created to detect the deltaN isoform of p63 (deltaNp63) with tumour suppressor role and differentiate from the TA (TAp63) isoforms of the same protein. Binding specificity: within MLYLENNAQTQFSE. No cross-reaction with p53 or p73 isoforms. Specificity verified by CRISPR-knockout and shRNA knockdown.
  • Immunogen: peptide MLYLENNAQTQFSE of tumour protein p63 (deltaN isoform) coupled to keyhole limpet hemocyanin
  • Isotype: IgG1 kappa
  • Production details: B cell donor: Splenocytes from mouse immunised with peptide MLYLENNAQTQFSE, Fusion partner: SP2

Target Details

  • Target: tumour protein p63 lacking the transactivation domain (TA)
  • Molecular weight: 72 kDa
  • Target background: p63 is a transcription factor of the p53 gene family, encoded by the TP63 gene located at chromosome 3q28. p63 exists as N-terminal isoforms that either contain (TAp63) or lack (deltaNp63) the p53-like transactivation domain at the N-terminus. C-terminal isoforms are produced by alternative splicing of 3' exons. TAp63 is involved in germ cell maintenance and myocyte differentiation, and is expressed in some lymphocytes and lymphomas/leukemias.
  • Epitope sequence: MLYLENNAQTQFSE sequence of tumour protein p63 (deltaN isoform)

Handling

  • Format: Liquid
  • Shipping conditions: Dry ice

References

  • Orzol et al. 2016. Tumour Biol. Aug:37(8):10133-40. PMID: 26825981
  • Galoczova et al. 2021. Virchows Arch. Apr:478(4):627-636. PMID: 33037932
  • Pokorna et al. 2022. Front Oncol. Jul 14:12:924354. PMID: 35912168

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.